Cargando…

Emodin inhibits the proliferation of papillary thyroid carcinoma by activating AMPK

Emodin has been demonstrated to serve antitumor roles in a variety of tumor types, but the effect of emodin on papillary thyroid carcinoma and its molecular mechanisms remain unclear. In the current study, the role of emodin on papillary thyroid carcinoma was analyzed in vitro and in vivo. TPC-1 cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Weilong, Wang, Dong, Li, Meijing, Li, Baoyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355685/ https://www.ncbi.nlm.nih.gov/pubmed/34447468 http://dx.doi.org/10.3892/etm.2021.10509

Ejemplares similares

BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor
por: Zheng, Haitao, et al.
Publicado: (2016)

Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ERα Inhibition
por: Huang, Pao-Hsuan, et al.
Publicado: (2013)

Emodin treatment of papillary thyroid cancer cell lines in vitro inhibits proliferation and enhances apoptosis via downregulation of NF‑κB and its upstream TLR4 signaling
por: Liu, Xin, et al.
Publicado: (2023)

Insulin‐like growth factor 1 promotes proliferation and invasion of papillary thyroid cancer through the STAT3 pathway
por: Yang, Li, et al.
Publicado: (2020)

LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma
por: Zhao, Shuiying, et al.
Publicado: (2015)

Suppression of CCT3 inhibits malignant proliferation of human papillary thyroid carcinoma cell
por: Shi, Xiaohui, et al.
Publicado: (2018)

MicroRNA-509 targets PAX6 to inhibit cell proliferation and invasion in papillary thyroid carcinoma
por: Zhang, Shuilong, et al.
Publicado: (2022)

RBM47/SNHG5/FOXO3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma
por: Qin, Yuan, et al.
Publicado: (2022)

Emodin in Rheum undulatum inhibits oxidative stress in the liver via AMPK with Hippo/Yap signalling pathway
por: Lee, Eun Hye, et al.
Publicado: (2020)

GPX7 promotes the growth of human papillary thyroid carcinoma via enhancement of cell proliferation and inhibition of cell apoptosis
por: Liu, Li-Dan, et al.
Publicado: (2019)

Long-Term Exposure to Decabromodiphenyl Ether Promotes the Proliferation and Tumourigenesis of Papillary Thyroid Carcinoma by Inhibiting TRß
por: Wang, Xinpei, et al.
Publicado: (2022)

Curcumin Inhibits Papillary Thyroid Cancer Cell Proliferation by Regulating lncRNA LINC00691
por: Li, Zhihua, et al.
Publicado: (2022)

Emodin inhibits the proliferation and migration of B16F10 cells and induces their apoptosis
por: Yuan, Mingjie, et al.
Publicado: (2020)

FOXP4-AS1 Inhibits Papillary Thyroid Carcinoma Proliferation and Migration Through the AKT Signaling Pathway
por: Luo, Xue, et al.
Publicado: (2022)

An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis
por: Lamba Saini, Monika, et al.
Publicado: (2016)

TET3 Mediates 5hmC Level and Promotes Tumorigenesis by Activating AMPK Pathway in Papillary Thyroid Cancer
por: Chi, Jiadong, et al.
Publicado: (2022)

The LINC01186 suppresses cell proliferation and invasion ability in papillary thyroid carcinoma
por: Wang, Nanpeng, et al.
Publicado: (2018)

Emodin enhances osteogenesis and inhibits adipogenesis
por: Yang, Feng, et al.
Publicado: (2014)

Kiss1 Inhibits the Proliferation of Nasopharyngeal Carcinoma Cells Via Activation of the LKB1/AMPK Pathway
por: Li, Tingting, et al.
Publicado: (2022)

BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma
por: WANG, YONG, et al.
Publicado: (2014)

Significant Correlation of Telomerase Activity in Thyroid Papillary Carcinomas with Cell Differentiation, Proliferation and Extrathyroidal Extension
por: Okayasu, Isao, et al.
Publicado: (1997)

Cell Metabolomics Reveals the Potential Mechanism of Aloe Emodin and Emodin Inhibiting Breast Cancer Metastasis
por: Cheng, Guorong, et al.
Publicado: (2022)

p63 inhibits CD44(+)/CD24(−) cell proliferation and chemoresistance in papillary thyroid carcinoma cells
por: Guo, Jing-Jing, et al.
Publicado: (2017)

Emodin inhibits LOVO colorectal cancer cell proliferation via the regulation of the Bcl-2/Bax ratio and cytochrome c
por: MA, LIANG, et al.
Publicado: (2014)

Cpt1c regulated by AMPK promotes papillary thyroid carcinomas cells survival under metabolic stress conditions
por: Wang, Rui, et al.
Publicado: (2017)

Down-regulated HSDL2 expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma
por: Zeng, Jing, et al.
Publicado: (2019)

Validation of MicroRNA-188-5p Inhibition Power on Tumor Cell Proliferation in Papillary Thyroid Carcinoma
por: Zhou, Ping, et al.
Publicado: (2020)

The Comparison of the Efficiency of Emodin and Aloe-Emodin in Photodynamic Therapy
por: Nowak-Perlak, Martyna, et al.
Publicado: (2022)

Emodin Suppresses Hyperglycemia-Induced Proliferation and Fibronectin Expression in Mesangial Cells via Inhibiting cFLIP
por: Gao, Junjie, et al.
Publicado: (2014)

Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study
por: Yihao, Liu, et al.
Publicado: (2022)

Thirty synchronous medullary and papillary thyroid carcinomas
por: Zhang, Daqi, et al.
Publicado: (2023)

Thyroid papillary carcinoma associated to Hashimoto's thyroiditis
por: Campos, Luiz Alexandre Albuquerque Freixo, et al.
Publicado: (2015)

miR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression
por: Cheng, Hui, et al.
Publicado: (2018)

Papillary Thyroid Microcarcinomas Are Different from Latent Papillary Thyroid Carcinomas at Autopsy
por: Lee, Yong Sang, et al.
Publicado: (2014)

Hypervascularity is more frequent in medullary thyroid carcinoma: Compared with papillary thyroid carcinoma
por: Lai, Xingjian, et al.
Publicado: (2016)

Integrated bioinformatics analysis and screening of hub genes in papillary thyroid carcinoma
por: Fan, Rong, et al.
Publicado: (2021)

EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma
por: Xue, Liqiong, et al.
Publicado: (2019)

MiR-613 inhibits the proliferation, migration, and invasion of papillary thyroid carcinoma cells by directly targeting TAGLN2
por: Huang, Yonglian, et al.
Publicado: (2021)

Comparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid Carcinoma
por: Zhang, Bo, et al.
Publicado: (2016)

Synchronous primary hyperparathyroidism, follicular thyroid carcinoma, and papillary thyroid carcinoma
por: Dai, Dong-Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b6fq973hcato01oe0dudmsqumk